Skip to content
OpenCapital
Get started

Lexicon Pharmaceuticals LXRX Accretion (Amortization) of Discounts and Premiums, Investments

Accretion (Amortization) of Discounts and Premiums, Investments at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$6.19M-12.9%

Other financials

Income statement

See full
Revenue$21.1M+1,572%
Gross profit$21.0M+1,604%
Operating income-$996.0K+96.1%
Net income-$1.0M+95.9%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$67.1M+6.7%
Total debt$57.7M-45.7%
Total equity$202.9M+64.9%
Total assets$268.8M-9.7%

Cash flow

See full
Operating cash flow-$14.7M+66.4%
CapEx--100%
Free cash flow-$17.2M+21.5%

Valuation

See full
Market cap$986.12M+273%
Enterprise value$976.73M+219%
P/S14.2×+5.7×

Profitability

See full
Gross margin99.5%+1.5pp
Operating margin-34.8%-16.8pp
Net margin-37.5%-18.1pp
FCF margin-578.5%-283pp

Returns & leverage

See full
Return on equity-16%-7.2pp
Debt / equity0.3×-0.6×
Current ratio18.8×+16.6×

Where this comes from

Reported directly by Lexicon Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.

The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lexicon Pharmaceuticals's accretion (amortization) of discounts and premiums, investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lexicon Pharmaceuticals's accretion (amortization) of discounts and premiums, investments?
Lexicon Pharmaceuticals (LXRX) reported accretion (amortization) of discounts and premiums, investments of $562K in Q1 2026.
How has Lexicon Pharmaceuticals's accretion (amortization) of discounts and premiums, investments changed year-over-year?
Lexicon Pharmaceuticals's accretion (amortization) of discounts and premiums, investments decreased by 57.6% year-over-year, from $1.33M to $562K.
What does accretion (amortization) of discounts and premiums, investments mean?
This metric captures the periodic adjustment to the carrying value of investment securities to reflect the amortization of premiums or the accretion of discounts. It aligns the book value of an investment with its expected maturity value over time. It is a key indicator of how the company manages its treasury and investment portfolio yields.